HSV-1 Infection of Epithelial Dendritic Cells Is a Critical Strategy for Interfering with Antiviral Immunity

Viruses. 2022 May 14;14(5):1046. doi: 10.3390/v14051046.

Abstract

Herpes simplex virus type 1 (HSV-1), an α subgroup member of the human herpesvirus family, infects cells via the binding of its various envelope glycoproteins to cellular membrane receptors, one of which is herpes virus entry mediator (HVEM), expressed on dendritic cells. Here, HVEM gene-deficient mice were used to investigate the immunologic effect elicited by the HSV-1 infection of dendritic cells. Dendritic cells expressing the surface marker CD11c showed an abnormal biological phenotype, including the altered transcription of various immune signaling molecules and inflammatory factors associated with innate immunity after viral replication. Furthermore, the viral infection of dendritic cells interfered with dendritic cell function in the lymph nodes, where these cells normally play roles in activating the T-cell response. Additionally, the mild clinicopathological manifestations observed during the acute phase of HSV-1 infection were associated with viral replication in dendritic cells.

Keywords: dendritic cells; herpes simplex virus type 1; herpesvirus entry mediator; innate immune.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents
  • Dendritic Cells / pathology
  • Herpes Simplex*
  • Herpesviridae Infections*
  • Herpesvirus 1, Human* / physiology
  • Mice

Substances

  • Antiviral Agents

Grants and funding

This work was supported by the National Natural Science Foundation of China (No. 82171817 and No. 81802868) and grants from the Major Science and Technology Special Projects of Yunnan Province (No. 202001AU070142, No. 202002AA100009, No. 202005AD160006, No. H-2017035 and No. H-2019060).